Similar articles
Advertisement
Create a post to Start Earning on Pejoweb.
Learn how it works

Novavax Covid Vaccine Is Highly Effective In U.K. Trial



The Maryland-based biotech company Novavax reported Thursday that its experimental Covid-19 vaccine is more than 96 percent effective in preventing mild and severe illness.
The results are from the company's Phase 3 clinical trial, which was conducted in the U.K. Novavax's trials in the U.S. and South Africa continue, and the company cannot apply for emergency use authorization in the U.S. until the American trials are complete.
"We are very encouraged by the data," Stanley Erck, Novavax's president and CEO, said in a statement.
The U.K. trial included more than 15,000 adults. More than a quarter were 65 or older, an age group that is generally considered to be at higher risk for complications of Covid-19.
The two-dose vaccine was found to be more than 96 percent effective against earlier strains of the virus circulating in the U.K., putting it on par with vaccines already in use from Moderna and Pfizer-BioNTech.
Effectiveness was slightly lower — around 86 percent — against the more contagious B.1.1.7 variant, which was first identified in the U.K. The variant has already been detected in nearly half of U.S. states, and the Centers for Disease Control and Prevention has predicted that it will be the predominant variant by the end of the month.
The Novavax vaccine was also 100 percent effective against the most severe forms Covid-19, regardless of the variant — much like the other vaccines in use in the U.S.
The Biden administration has promised enough vaccine for all eligible Americans by the end of May. The goal is expected to be met with vaccines that are already available, from Moderna, Pfizer-BioNTech and Johnson & Johnson.
Advertisement




Log in to Like & Comment

 1 like
 
 






Xmocrew (Plus)   3 months ago
May God save us


Xmocrew (Plus)   3 months ago
Alright


Xmocrew (Plus)   3 months ago
Okay




Advertisement

Articles that may interest you


Astrazeneca Vaccine 76% Effective In Updated US Trial Result

AstraZeneca said its COVID-19 vaccine was 76% effective at preventing symptomatic illness in a new analysis of its major U.S. trial - a tad lower than...

 


The most potent and highly effective dietary supplement

The most potent andhighly effective dietary supplementLongjack XXXL150,000+ Satisfied Customers and Their Partners Can’t be Wrong!.For well over two...

 


Pfizer Launches Trial To Test Covid Vaccine In Children As Young As 6 Months

The first young children in the pediatric trial of the Pfizer-BioNTech Covid-19 vaccine have received their initial shots, company officials announced...

 


Kaiser Launches COVID-19 Vaccine Trial For Children 5 To 11 In Northern California

It’s been a hard year for 11-year-old Luci Guardino. Distance learning wasn’t easy, and she missed being able to have her friends over.That’s wh...

 


Major new trial of covid-19 vaccine in UK

The jab - designed by the Belgian company Janssen - uses a genetically modified common cold virus to train the immune system.It comes a week after pre...

 

Advertisement

Uploads that may interest you

Volume 9. Selected and Prepared by United Nations War crime commission

Laugh laugh 😄 out ur Sorrows

Advertisement

Loading...
 
 | 
 | 
Policy
 | 
Pejoweb © 2021